BioVie Inc. Class A (BIVI)
NASDAQ: BIVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BIVI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $12.16M
- EPS (TTM)
- -$3.05
- Dividend yield
- None
- 52-week range
- 0.82 – 3.79
- Day range
- 1.40 – 1.47
- Volume / Avg
- 118.72K / 4.67M
- Beta
- —
- Shares outstanding
- 8.68M
- Next earnings
- Nov 9, 2026
52-week range
BIVI stock today
On Oct 7, BIVI ended the session at $1.40, shedding $0.04 (2.78%), versus the S&P 500's 0.22% decline. Trading was light, with 118.72K shares changing hands, about 3% of the average daily volume. At this level, BIVI sits near the bottom of its 52-week range of $0.82 to $3.79: 63.1% below the high, set on Aug 12, 2026 and 70.7% above the low.
BIVI is up 20.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 30.3%. BioVie has posted a net loss over the last twelve months (EPS of -$3.05), so its P/E ratio is not meaningful. BioVie's next earnings report is expected on Nov 9, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About BioVie
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Carson City, NV
Earnings
Earnings history- Next report
- Nov 9, 2026
BioVie peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ASBPAspire-Lakewood Holdings Inc. | 8.63 | -1.48% | $12.10M | vs BIVI |
| GDTCCytoMed Therapeutics Limited | 0.98 | +5.40% | $11.70M | vs BIVI |
| LSTALisata Therapeutics Inc. | 1.17 | -3.31% | $12.64M | vs BIVI |
| PHIOPhio Pharmaceuticals Corp. | 0.9995 | +0.51% | $11.61M | vs BIVI |
| MDCXMedicus Pharma Ltd. | 0.1602 | +0.63% | $11.49M | vs BIVI |
| KPRXKiora Pharmaceuticals Inc. | 2.53 | +1.20% | $11.19M | vs BIVI |
| GTBPGT Biopharma Inc. | 6.20 | -2.67% | $11.19M | vs BIVI |
| BFRGBullfrog AI Holdings Inc. | 0.7086 | +2.84% | $13.14M | vs BIVI |
Indexes, lists and sector
BioVie stock FAQ
What is BioVie's stock price today?
BIVI last traded at $1.40 as of Oct 7, 4:00 PM EDT, down 2.78% on the day. Prices are delayed at least 15 minutes.
Does BioVie pay a dividend?
No. BioVie does not currently pay a regular cash dividend.
When is BioVie's next earnings date?
BioVie is expected to report earnings on Monday, November 9, 2026.
Has BIVI ever split its stock?
Yes. The most recent BIVI stock split was a 1-for-10 split on Jul 7, 2025, one of 2 splits on record.
What is the BIVI 52-week high?
The 52-week high for BIVI is $3.79 and the 52-week low is $0.82. The stock is currently 63.1% below its high.